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Summary
Objective: Partial meniscectomy is known to cause osteoarthritis (OA) of the underlying cartilage as well as alter the load on the remaining
meniscus. Removal of 30e60% of the medial meniscus increases compressive strains from a maximum of approximately 10% to almost 20%.
The goal of this study is to determine if meniscal cells produce catabolic molecules in response to the altered loading that results from a partial
meniscectomy.
Method: Relative changes in gene expression of interleukin-1 (IL-1), inducible nitric oxide synthase (iNOS ) and subsequent changes in the
concentration of nitric oxide (NO) released by meniscal tissue in response to compression were measured. Porcine meniscal explants were
dynamically compressed for 2 h at 1 Hz to simulate physiological stimulation at either 10% strain or 0.05 MPa stress. Additional explants were
pathologically stimulated to either 0% strain, 20% strain or, 0.1 MPa stress.
Results: iNOS and IL-1 gene expression and NO release into the surrounding media were increased at 20% compressive strain compared to
other conditions. Pathological unloading (0% compressive strain) of meniscal explants did not significantly change expression of IL-1 or iNOS
genes, but did result in an increased amount of NO released compared to physiological strain of 10%.
Conclusion: These data suggest that meniscectomies which reduce the surface area of the meniscus by 30e60% will increase the catabolic
activity of the meniscus which may contribute to the progression of OA.
ª 2008 Osteoarthritis Research Society International. Published by Elsevier Ltd. All rights reserved.
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Partial meniscectomy is a common treatment for meniscal
tears which do not heal due to the lack of vascularity in
the inner two-thirds of the tissue. Partial meniscectomy
has been shown to lead to osteoarthritis (OA) in the long
term1,2. The amount of tissue removed has a bearing on
the severity of the onset of OA2, the loads carried by the
meniscus3, and the cellular environment of fibrochondro-
cytes within the tissue4. Hellio Le Graverand et al. 5 used
ACL transection as an experimental model of OA to capture
early changes in meniscal tissue and articular cartilage.
This study showed that extracellular matrix deterioration
and changes in cell and collagen distribution occurred in
the menisci prior to any changes in articular cartilage.
This suggests that meniscal tissue degeneration may be*Address correspondence and reprint requests to: Tammy L.
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1213a precursor to the development of OA. Although the mech-
anism by which articular cartilage degrades has been
widely studied, the mechanism of meniscal tissue degener-
ation and its association with OA are not clear. However,
two biomolecules, nitric oxide (NO)6,7 and interleukin-1
(IL-1)8e10, are believed to regulate catabolic activity in
both articular cartilage and meniscus.
NO is an important intracellular and extracellular messen-
ger serving different functions in a variety of tissues11. NO
causes tissue degeneration12,13 and apoptotic cell death
in cartilage and meniscus6,7. NO is produced by a family
of enzymes called nitric oxide synthases (NOSs), two of
which, NOS1 and NOS3, are constitutive forms and the
third, NOS2 or inducible nitric oxide synthase (iNOS) is an
inducible form. NO production within cartilaginous tissues
such as articular cartilage and meniscus has been previ-
ously shown to be primarily of the inducible form and is
regulated by chemical and mechanical stimuli11e15,18. While
it has previously been shown that meniscal cells can make
both NOS2 and NOS319, it is the inducible form of NOS that
can be activated by inflammatory mediators such as IL-1
and tumor necrosis factor11.
Table I
Change in pressures over the duration of meniscal tissue stresse
relaxation tests. Data represent mean standard deviation. n¼ 6
for all groups
Strain (%) Pressure (MPa)
Start End
5 0.166 0.108*,y 0.038 0.010y
10 1.141 0.103y 0.046 0.010y
15 2.185 0.827 0.035 0.026y
20 3.548 0.429 0.128 0.020
*Significantly different than 15% (P< 0.05).
ySignificantly different than 20% (P< 0.05)21.
1214 T. Gupta et al.: IL-1, iNOS and NO expression from meniscal explantsIL-1, an inflammatory cytokine, has been shown to in-
crease the production of NO in meniscal and articular carti-
lage11,12 and also reduce synthesis of the major articular
cartilage matrix protein (type II collagen), independently of
NO at a transcriptional or post-transcriptional level12. IL-1
also causes a decrease in the incorporation of proteins spe-
cific to collagen13. Exogenous IL-1 has been shown to reg-
ulate the production of prostaglandin E2 (PGE2). PGE2 is an
inflammatory mediator which inhibits synthesis of collagen 15,
via an NO dependant pathway and decreases proteoglycan
synthesis15,17. Taken together, this suggests a catabolic
role for IL-1 as collagen and proteoglycans constitute the
majority of the solid constituents of meniscal tissue.
Mechanical forces such as tension and compression are
essential for maintaining tissue homeostasis by balancing
the catabolic and anabolic activities of biomolecules20.
Mechanically loading cartilaginous tissue has been shown
to both inhibit15,18 and upregulate16,17 NO production in
articular cartilage and meniscus. This discrepancy may be
due to a dose dependent response of the tissue to loading
or tissue type. Although mechanical loading is a potent me-
diator of matrix synthesis and degeneration, it is not clear
which magnitudes of mechanical loading are catabolic and
which are anabolic in their overall effect on meniscal tissue.
It is our hypothesis that there exists an optimal level of com-
pression that will cause the lowest production of IL-1 and NO
and hence be least damaging to meniscal tissue. This level
may be w10% compression which is predicted to be the up-
per limit of the healthy range of strains within intact menis-
cus3. We also hypothesize that superior and deep tissues
will respond differently to the same loading by producing dif-
ferent amounts of NO and IL-1. These hypotheses will be
tested by measuring iNOS and IL-1 gene expression and
NO production in vitro in response to unconfined compres-
sion at levels below physiological loading (0%), physiologi-
cal levels (w10%) and supraphysiological loading (20%).
MethodsCOMPRESSION TESTINGTable II
Change in strains over the duration of meniscal tissue creep tests.
Data represent mean standard deviation. n¼ 6 for all groups
Pressure (MPa) Strain (%)
Start End
0.05 2.6 0.53 11.6 1.36
0.1 3.0 0.12 20.7 1.45*
*Significantly different than 0.05 MPa (P< 0.05)21.Stifle joints (knees) were obtained from 18-week-old pigs 24 h after death
(Mayo Foundation, Rochester, MN) giving a sample size of six animals. For
a given animal, both the medial and lateral menisci were excised using sterile
techniques and 24 explants (six from each of the four menisci in an animal)
measuring 6 mm in diameter and 5 mm in height were cored using a biopsy
punch (6 mm Biopunch, Fray Products Corp., Buffalo, NY). The bottom face
of each explant was trimmed to be parallel to the superior surface of the ex-
plants. The explants were cored perpendicular to the superior surface of the
meniscus and were taken primarily from the outer region. Explants were then
allowed to equilibrate for 48 h at 37C with 5% CO2 in media constituting
44.5% Dulbecco’s modified Eagle medium (DMEM), 44.5% Ham’s F12,
10% fetal bovine serum (FBS) and 1% penicillin streptomycin. Media were
changed after 24 h of incubation.
Mechanical compression was achieved with a previously validated biore-
actor21. Briefly, the bioreactor was designed to test six explants simulta-
neously in unconfined compression. Six frictionless Delrinª (DuPont,
Willmington, DE) compression rods were driven by a stepper motor to com-
press explants in individual wells while housed in a sterile casing. A static
pre-stress of 0.0076 MPa was applied prior to dynamic compression.
Dynamic tests were then carried out at 37C at 0%, 5%, 10%, 15% or
20% strain and also at 0.05 MPa or 0.1 MPa stress for 2 h at 1 Hz. There-
fore, 0% strain actually refers to the amount of dynamic strain superim-
posed on top of the static 0.0076 MPa of pre-stress, and 0 MPa stress is
actually no dynamic stress superimposed on top of the static 0.0076 MPa
of pre-stress. The bioreactor used in the current study was previously pre-
sented with details of the stress and strain waveforms21. Tables I and II
present a brief summary of the stress and strain tests. Neither confined
or unconfined compression exactly replicates the in vivo environment of
meniscal tissue. While previous computational modeling has documented
the strain levels in the normal and meniscectomized menisci, unconfined
compression to similar strain levels leads to abnormally large stresses on
the tissue explant. Therefore, since the loading history is quite different be-
tween a stress controlled test and a strain controlled test, stress controlledexperiments were also completed to determine differences between these
two different mechanical effects. The stress levels were chosen such that
they represent approximately the equilibrium values found during stress re-
laxation studies of meniscal tissue. For the 10% stress relaxation studies,
equilibrium stress was approximately 0.05 MPa. For 20% stress relaxation
studies, 0.1 MPa was the equilibrium stress. Hence, 0.05 MPa is consid-
ered to be physiologically normal, whereas 0.1 MPa is considered to be
supraphysiological, or overloading21.
Following mechanical loading, explants were removed from the bioreactor,
cut into half to distinguish between superior and deep portions, weighed and in-
cubated for 24 h in 1 ml of media similar in composition to that used for equilibra-
tion but containing 2% FBS. Explants were then removed from the media and
stored in 200e300 ml of RNALater (Ambion Inc., Austin, TX) at 4C for 1 day.
RNALater was then removed and the samples were stored at20C. Post-com-
pression media were stored in 1.5 ml vials at 80C for subsequent analysis.RNA ISOLATIONTotal RNA was isolated from superior and deep sections of the explants
using a commercial kit (SV Total RNA Isolation System, Promega, Madison,
WI). Three explants were combined and crushed to a fine powder using
liquid nitrogen. Preliminary data showed that combining three explants pro-
vided sufficient RNA for subsequent polymerase chain reaction (PCR) anal-
yses. The powder was immediately added to lysis buffer and then stored at
4C. A homogenizer was used to lyse the cells further. RNA was extracted
and DNase-treated on the column according to the manufacturer’s instruc-
tions. RNA was eluted in 100 ml of nuclease free water, analyzed with a spec-
trophotometer and run on a 1.5% native agarose gel to check for integrity by
observing the 18S rRNA and 28S bands.PRIMERS DESIGNSpecific primers were design based on Sus scrofa sequence (either par-
tial or complete mRNA) available from the National Center for Biotechnology
Information (NCBI). Amplicon sizes ranged from 150 bp to 260 bp and
primers were approximately 20 bp long (Table III). PCR was performed using
gene-specific primers and the products were verified by sequencing.SEMI-QUANTITATIVE REVERSE TRANSCRIPTION-PCR
(RT-PCR)RT-PCR was performed using a two step process. First-strand RT was
synthesized using Superscript II (Invitrogen Corporation, CA) and random
primers. PCR was carried out for 28 cycles at an annealing temperature of
58C using cDNA equivalent to 300 ng of RNA. cDNA used for amplifying
18S rRNA was diluted 1/40 to allow both iNOS and 18S rRNA to be amplified
to similar levels, within the linear range of amplification, using the same cycle
number and annealing temperature. PCR products were run on a 2.5% aga-
rose gel and a digital image was taken. MATLAB (The MathWorks Inc.,
Table III
Sequences of designed primers for all genes




18S rRNA GCAAATTACCCACTCCCGAC CGCTCCCAAGATCCAACTAC
*Primers from literature 41.
1215Osteoarthritis and Cartilage Vol. 16, No. 10Natick, MA) was used to measure the intensities of each band on the gel.
Relative changes (increases or decreases) in the concentration of iNOS in
each sample were recorded as intensities of the bands of iNOS normalized
to the intensities of the corresponding bands of 18S rRNA. To validate
a semi-quantitative PCR for iNOS, PCR was first conducted for 26e30 cy-
cles, and annealing temperatures up to 63C were checked. Sequencing
was completed on the gel to ensure proper product.REAL-TIME PCRReal-time PCR with SYBR Green mix (Absolute QPCR SYBR Green Mix,
ABgene Inc., NY) detection was used to quantify the expression of both types
of IL-1: a and b. The efficiency of amplification was calculated for each gene
from a standard curve. Average values (82.7% e IL-1a, 87% e IL-1b, 88.25% e
18S rRNA) of efficiency were used in further analysis. Since the Pfaffl22
method was used to analyze the results, a calibrator was run with each test
for both genes of interest and the housekeeping gene (18S rRNA). Each sam-
ple was run for 40 cycles (95C/15 s, 59C/45 s, 72C/40 s) and each 25 mL
reaction contained 15 ng of cDNA and 1 mL of carboxy-X-rhodamine (ROX)
reference dye (Absolute QPCR SYBR Green Mix, ABgene Inc., NY) to nor-
malize the fluorescence. Primer concentrations were 2.5 mM, 5 mM and
10 mM for IL-1a, IL-1b and 18S rRNA, respectively. ROX was diluted to
0.25%. All samples were run in duplicate. A dissociation curve was run with
each plate setup to confirm regularity of the tests. Samples were analyzed us-
ing the Pfaffl method by which the ratio of the target gene to the housekeeping






where Ct e cycle number in the linear range of amplification, E e efficiency of
the process for each gene, target e gene of interest, ref e housekeeping
gene, control e calibrator, treated e sample.
All samples were normalized to controls (either 0% strain or 0 MPa stress)
from each animal.NO QUANTIFICATIONNO release was quantified using a commercially available kit (Nitrate/Nitrite
Colorimetric Assay Kit, Cayman Chemical Company, Ann Arbor, MI). Since
the final products of NO in vivo are nitrite (NO2
) and nitrate (NO3
), the best
quantification of total NO production is the sum of the concentration of each.
Hence, this assay measured total NO concentration in two steps. In the first
step nitrate was converted to nitrite utilizing nitrate reductase. In the second
step nitrite was converted into a deep purple azo compound through a Griess
reaction. Absorbance of colored azo was measured and then converted to total
NO concentration (mM) using a standard curve. All measurements were taken
in duplicate. The final concentration was normalized by wet weight (g) of the
explants. Since proteins are known to interfere with the Griess reaction, condi-
tioned media were filtered using a 10,000 molecular weight cut-off filters before
it was assayed (Millipore Microcon YM-10, Bedford, MA).DATA ANALYSISAll data are presented as mean standard error. A one way analysis of
variance (ANOVA) followed by Fisher’s protected least significant difference
(PLSD) testing was used to measure statistical differences (p< 0.05 was
considered significant). Paired t tests were used at each stress or strain level
to determine differences between superior and deep zones.Results
Fig. 1. Relative iNOS gene expression in superior (white) and deep
(black) zones of meniscal explants after unconfined compression toRELATIVE iNOS GENE EXPRESSION
0%, 5%, 10%, 15% or 20% (A) and 0.0 MPa, 0.05 MPa or 0.1 MPa
(B). *Significantly different than 0% compression superior zone.
#Significantly different than superior zone for the same strain.Superior explants tested at 20% strain showed the largest
iNOS gene expression compared to other strain levels[Fig. 1(A)]. Compared to the uncompressed samples, 20%
compression significantly upregulated iNOS gene expres-
sion. Samples from the superior zone expressed slightly
greater amounts of iNOS compared to deep regions for
each compression level (statistical significance at 0% and
1216 T. Gupta et al.: IL-1, iNOS and NO expression from meniscal explants10% compression) [Fig. 1(A)]. No differences between
stress levels were noted for iNOS expression [Fig. 1(B)].RELATIVE IL-1a EXPRESSIONA significant increase in IL-1a gene expression was seen
for explants strained to 20% compared to other tested levels
for both superior and deep zones [Fig. 2(A)]. There were no
significant differences between superior and deep regions
for IL-1a [Fig. 2(A) and (B)]. As with iNOS expression, no
significant differences between stress levels were seen.
The greatest expression of IL-1a occurred with 0.05 MPa
of stress from the deep zone [Fig. 2(B)].RELATIVE IL-1b EXPRESSIONWhile the superior and deep zones behaved similarly for
expression of IL-1a, the expression of IL-1b is different be-
tween zones. No statistical differences were noted in the
superior zones across the different strain levels. IL-1b
gene expression was significantly upregulated with 10% dy-
namic compressive strain compared to 0% dynamic com-
pressive strain in the deep zone explants [Fig. 3(A)]. The
only significant difference between superior and deep
zone explants was for 10% dynamic compressive strain,
with the deep zone expressing more than double that of
the superior zone [Fig. 3(A). For the stress experiments,
IL-1b follows the same trend as iNOS, and IL-1a with ex-
pression following 0.05 MPa stress being the highest
[Fig. 3(B)].Fig. 2. Relative (to 18S rRNA) changes in IL-1a after compression
to (A) 0%, 5%, 10%, 15% or 20% strain and (B) 0.05 MPa or
0.1 MPa. *Significantly different than 20% strain superior zone,
^significantly different than 20% strain deep zone, #significantly
different than 0% superior zone.
Fig. 3. Relative (to 18S rRNA) changes in IL-1b after compression
to (A) 0%, 5%, 10%, 15% or 20% and (B) 0.05 MPa or 0.1 MPa.
$Significantly different than 10% compressive strain deep zone.NO RELEASEThe lowest release of NO was seen in superior samples
strained to 10% compression compared to 0%, 5%, 15%
and 20% compressive strains [Fig. 4(A)]. There were no
statistical differences between superior and deep zones
samples or the stress control samples [Fig. 4(A) and (B)].Discussion
Samples taken from both the superior and deep zones
support the hypothesis of this study showing the lowest
NO release for samples compressed to 10%. Additionally
IL-1b gene expression was the lowest at 10% compression
for superior explants. In previous studies, the positive ef-
fects of compression on protein and proteoglycan incorpo-
ration (measures of matrix synthesis) were eliminated by
the addition of IL-1 but restored in the presence of IL-1
once NO was blocked17. This may indicate that compres-
sion acts on IL-1, which then mediates the production of
NO, which in turn mediates tissue degeneration23. While
others have studied the iNOS/NO response of meniscal
tissue to loading24,16, this study is novel in that a loading
scheme has been chosen that can be related to the conse-
quences of partial meniscectomy.
Compressive strains of 20% resulted in the highest ex-
pression/release of iNOS, IL-1a and NO. Similar results
were obtained in a previous study that measured the re-
lease of glycosaminoglycans (GAG) into the media follow-
ing dynamic compression21. 20% strain is considered
pathological and removing 30e60% of the meniscus during
Fig. 4. NO released into media measured as concentrations of
nitrite for explants compressed to 0%, 5%, 10%, 15% or 20% strain
(A) and 0.0 MPa, 0.05 MPa or 0.1 MPa (B). Results are standard-
ized with respect to the wet weight of the tissue. *10% superior is
significantly different than 20%.
1217Osteoarthritis and Cartilage Vol. 16, No. 10a partial meniscectomy increases the strains to approxi-
mately 20%3. This upregulation of catabolic gene expres-
sion may be a precursor to meniscal degeneration and
subsequent OA.
Kobayashi et al.7 showed that cells from superior zones
of the meniscus produced more NO compared to cells from
the deep zone following partial meniscectomy. This agrees
with our finding in that superior sections of explants
showed some significant differences in NO release at vary-
ing compression levels perhaps indicating that the superfi-
cial zone is more sensitive to variations in the mechanical
environment compared to the deep zone. Cells from the
superior zone of meniscal tissue are thought to be more
elliptical or fibroblastic compared to cells from the deeper
regions that are more spherical or chondrocytic. A finite el-
ement model of a chondron within meniscal tissue showed
that fibroblastic cells experience larger strains and stresses
than chondrocytic cells4. Inhomogeniety between the mate-
rial properties of superior and deep tissues25e27 may cause
cells in the superior region to be more sensitive to com-
pression regardless of morphology. In this study we did
not characterize cell populations following division. This
may be a reason for the lack of statistical differences be-
tween superior and deep samples.
Knee joint immobilization has been shown to decrease
aggrecan gene expression in intact menisci which may
lead to tissue degradation28. However, our study did not
show increases in iNOS, IL-1a or IL-1b gene expression
for underloaded samples (0% and 0 MPa). On the otherhand, NO release was higher for uncompressed explants
compared to explants compressed to 5% or 10%. This dis-
crepancy between iNOS gene expression and NO release
may be due to the duration of post-incubation. For example,
Bonassar et al.29 showed that the time taken for protein
synthesis to occur in articular cartilage stimulated with insu-
lin like growth factor-1 (IGF-1) vs mechanical compression
was 12.2 h vs 2.9 h, respectively. Both iNOS gene expres-
sion and NO release were measured 24 h post-treatment in
this study and disuse was modeled as the absence of
loading.
It is also conceivable that a relatively lower level of iNOS
gene expression may cause a relatively higher level of NO
synthesis for unloaded explants compared to explants
compressed to 5%. The stability of iNOS mRNA is impor-
tant for iNOS induction30. Factors which control the transla-
tion of iNOS mRNA into iNOS enzyme and/or the synthesis
of NO by the iNOS enzyme may be sensitive to loading.
This may explain the discrepancy between the reduced
iNOS gene expression at 0% compression and the in-
creased NO release at 0% compression compared to 5%
compression.
A comparison of the stress experiments vs the strain
experiments highlights a few differences in the tissue re-
sponse. Firstly, while it was expected that 0.1 MPa experi-
ments and 20% strain experiments would yield similar
results since both conditions result in overloading of the
tissue, the stress experiments to 0.1 MPa did not result in
a significant upregulation of iNOS compared to 0.0 MPa
or 0.05 MPa of stress. This is likely due to the fact that
the 20% strain explants were subjected to much larger
stresses initially (3.5 MPa) whereas the stress control ex-
periments were not. It is perhaps this large initial stress dur-
ing the 20% strain control experiments that is responsible
for the increased iNOS and IL-1 gene expression.
Both IL-1a and IL-1b have been implicated in the patho-
physiology of OA31,32. Others have shown that exogenous
IL-1b added to chondrocytes increases NO production33,23.
Exogenous IL-1a and IL-1b have both been shown to in-
crease the production of PGE2
34, decrease proteoglycan
synthesis35, and increase proteoglycan degradation35.
When exogenous IL-1a was added to human articular car-
tilage a marked loss in proteoglycan was shown to occur36.
A direct link between exogenously added IL-1a, iNOS and
NO has been previously established37. The difference be-
tween these previous studies and the current study is that
no exogenous IL-1a or IL-1b was added to the meniscal ex-
plants. The current study shows significant upregulation of
IL-1a gene with pathological overloading (20% strain) for
both the superior and deep zones. Approximately 10 mole-
cules of IL-1b are needed to activate a signaling pathway38.
Hence, biologically significant changes in IL-1b gene ex-
pression may have been masked by differences in gene
expression between animals. To our knowledge, expres-
sion of IL-1 by meniscal tissue following mechanical stimu-
lation has not previously been studied.
This study is a step forward in understanding the mecha-
nisms of compression induced changes in biochemical
activity in meniscal tissue which may ultimately change its
material properties.
Although this study shows that IL-1 and iNOS gene ex-
pression are regulated by compression in a similar manner,
further investigation is required to elucidate the interaction
of these two genes. Although others have studied the
effects of adding IL-1 to tissue exogenously13,39,40,17, mea-
surement of iNOS gene expression once IL-1 is blocked will
clarify the dependence of iNOS gene expression on IL-1.
1218 T. Gupta et al.: IL-1, iNOS and NO expression from meniscal explantsAdditionally, this study has only documented gene expres-
sion for IL-1, thus it is not yet known if IL-1 protein is
made or if the IL-1 has any activity. Future studies are
directed toward studying the various zones of the tissue
as well as blocking studies to determine the mechanism
of response.
In conclusion, this study shows that catabolic activity,
specifically iNOS and IL-1a gene expression and subse-
quent NO release, is dependent on the magnitude of me-
chanical loading in vitro. Results show an increase in
iNOS and IL-1a gene expression and NO release when me-
niscal tissue is compressed to pathological overloading
compared to physiological levels of load. The results of
this study, taken together with studies3, may indicate that
degeneration of meniscal tissue will result from altered load-
ing induced by 30% or more partial meniscectomy whereby
leading to OA.Conflict of interest
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